BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37767820)

  • 21. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
    Luxton G; Keall PJ; King CR
    Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
    Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
    Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy.
    Svolos P; Tsougos I; Kyrgias G; Kappas C; Theodorou K
    Australas Phys Eng Sci Med; 2011 Apr; 34(1):69-81. PubMed ID: 21213098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ipsilateral lung normal tissue complication probability parameters for different dose calculation algorithms in radiotherapy of breast cancer.
    Kavousi N; Nedaie HA; Gholami S; Esfahani M; Shafiekhani S; Hassani M
    J Cancer Res Ther; 2020; 16(6):1323-1330. PubMed ID: 33342791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
    Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
    Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
    Kanehira T; van Kranen S; Jansen T; Hamming-Vrieze O; Al-Mamgani A; Sonke JJ
    Radiother Oncol; 2021 Nov; 164():209-215. PubMed ID: 34619234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics.
    Patel G; Mandal A; Bharati A; Choudhary S; Mishra R; Mourya A
    J Cancer Res Ther; 2022; 18(6):1697-1705. PubMed ID: 36412432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Hepatitis B Virus Reactivation After Radiotherapy in Patients With Hepatocellular Carcinoma Using the Lyman NTCP Model.
    Li Z; Dong Y; Fan M; Yin Y; Zhu J; Li B; Huang W
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819875136. PubMed ID: 31526114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
    Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
    Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer.
    Li Y; Li P; Hsi W; Hong Z; Fu S; Zhang Q
    Radiother Oncol; 2021 Mar; 156():69-79. PubMed ID: 33309999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.
    Kwa SL; Theuws JC; Wagenaar A; Damen EM; Boersma LJ; Baas P; Muller SH; Lebesque JV
    Radiother Oncol; 1998 Jul; 48(1):61-9. PubMed ID: 9756173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer.
    Fukahori M; Matsufuji N; Himukai T; Kanematsu N; Mizuno H; Fukumura A; Tsuji H; Kamada T
    Radiother Oncol; 2016 Jan; 118(1):136-40. PubMed ID: 26700600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of different dose calculation algorithms on the estimate of NTCP for lung complications.
    Hedin E; Bäck A
    J Appl Clin Med Phys; 2013 Sep; 14(5):127-39. PubMed ID: 24036865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.